Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (11): 875-880.doi: 10.12372/jcp.2022.21e1762

• Continuing Medical Education • Previous Articles    

Clinical research progress on neonatal sepsis induced by Streptococcus agalactiae

CHEN Biao, ZHAO Ruiqiu()   

  1. Department of Infection, Children’s Hospital of Chongqing Medical University; Ministry of Education Key Laboratory of Child Development and Disorders; National Clinical Research Center for Child Health and Disorders (Chongqing); China International Science and Technology Cooperation Base of Child Development and Critical Disorders; Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
  • Received:2021-12-24 Online:2022-11-15 Published:2022-11-10
  • Contact: ZHAO Ruiqiu E-mail:zrq0907@yeah.net

Abstract:

Sepsis is a key cause of neonatal death, andstreptococcus agalactiae is a common pathogen of neonatal sepsis. In recent years, some progress has been made in the diagnosis, treatment and prevention of neonatal sepsis induced by Streptococcus agalactiae. Western countries have issued and updated corresponding clinical guidelines, which have promoted the development of clinical diagnosis and treatment of this disease. This article gives a brief introduction the clinical research progress of neonatal sepsis induced by Streptococcus agalactiae at home and abroad.

Key words: streptococcus agalactiae, sepsis, neonate